C-section scar pregnancy: which treatment is safer?
NCT ID NCT07166627
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compares two procedures for treating type II cesarean scar pregnancy, a rare condition where a pregnancy implants in a previous C-section scar. 68 women in their first trimester will be randomly assigned to either surgical removal or ultrasound-guided evacuation. The goal is to see which method is safer and more effective, looking at outcomes like bleeding and recurrence.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If this trial succeeds, it could show which procedure is safer and more effective for treating cesarean scar pregnancy, helping doctors choose the best option.
- What could go wrong
- This is a small, early-stage study with only 68 participants, so results may not apply to all patients. Both procedures carry risks like bleeding or recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 68 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients diagnosed with cesarean section scar ectopic pregnancy type II and undergoing treatment in sohag university hospital.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients diagnosed with cesarean scar ectopic pregnancy Type II in the 1st trimester. Exclusion Criteria: * patients with cesarean scar pregnancy type 2 above 14 weeks. * Type I and type III cesarean section scar pregnancy. * patients presented with massive bleeding or shock. * Heterotopic pregnancy. * Simultaneous Hysterectomy or Sterilization.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cesarean scar pregnancy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sohag University Hospital
RECRUITINGSohag, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.